From: Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
Stimulus | NP composition | CRISPR-Cas9 format | Target gene locus | Applications | Administration route | Refs. |
---|---|---|---|---|---|---|
Light (808Â nm) | Gold nanorods with protector DNA | sgRNA | EGFP; EMX1; PLK-1 | In vitro (GFP and Cas9-expressing A549 epithelial carcinoma cells, HEK293T human embryonic kidney cells) | - | [199] |
Light (980Â nm) | UCNP anchored with 4-(hydroxymethyl)-3-nitrobenzoic acid and coated with PEI | RNP | EGFP; PLK-1 | In vivo (A549 epithelial carcinoma in BALB/c nude mice) | Intratumoral injection | [210] |
Ultrasound | Porphyrin-integrated nMOFs coated with PEI | RNP | EGFP; MTH1 | In vivo (A549 epithelial carcinoma in BALB/c nude mice) | Intravenous injection | [218] |
Ultrasound | Lipid nanobubble containing SF6 and conjugated with nanoliposome | RNP | SRD5A2 | In vivo (C57/B6 mice) | Being applied to the depilated area | [226] |
Magnetic | Baculoviral vectors bound with magnetic iron oxide nanoparticles | CRISPR-Cas9 plasmid | EGFP; VEGFR2 | In vivo (Hepa 1–6 hepatoma in athymic nude mice and C3 knockout mice) | Intratumoral and intravenous injection | [231] |